Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 6 days agoPfizer stock surged Wednesday after the pharma giant walloped analysts' first-quarter earnings...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 6 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
An effective treatment for COVID-19 is underused - The Advocate-Messenger
The Danville Advocate-Messenger· 6 days agoIn a clinical trial, the orally taken medication reduced the risk of hospitalization and death by...
Kendrick-Holmes: Why I thought of MerleFest when I got a prescription for Paxlovid
Winston-Salem Journal· 3 days agoYes, I had COVID. When the friendly nurse practitioner broke the news, I immediately thought of...
Pfizer revenues drop due to lower COVID-related product demand By Proactive Investors
Investing.com· 6 days agoPfizer reported a diluted earnings per share of $0.55, with an adjusted figure of $0.82, reflecting...
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To...
Benzinga via Yahoo Finance· 6 days agoWednesday, Pfizer Inc. (NYSE:PFE) reported first-quarter adjusted EPS of $0.82, down 33% year over...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 6 days agoTotal revenues however beat the Zacks Consensus Estimate of $13.86 billion. The revenue decline, as...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 6 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...